2026 NPPES data Allergy & Immunology Physician NPI 1972864064 MD
Verify on CMS →

AMY SCHIFFMAN, MD

Allergy & Immunology Physician in BOCA RATON, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
708
Medicare Part D claims · 232 beneficiaries · Allergy & Immunology Physician avg: 764
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$4.1K
64 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

AMY SCHIFFMAN, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 708 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
708
Part D claims, 2023
61%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AMY SCHIFFMAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

AMY SCHIFFMAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AMY SCHIFFMAN, MD?

Below national average

NPI registry status

Active

Issued 06/05/2012

NPI 1972864064

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

708 7% vs specialty avg

2023 prescription claims

Specialty avg: 764

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Allergy & Immunology Physician compares to other specialties among Florida providers

Florida providers

Allergy & Immunology Physician share within Florida

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within Florida

Medicare quality performance — MIPS

AMY SCHIFFMAN, MD's 2023 MIPS final score plotted against the Allergy & Immunology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Allergy & Immunology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Allergy & Immunology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMY SCHIFFMAN, MD appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding MD credentials at 7100 CAMINO REAL STE 121, BOCA RATON, FL, 33433, with a listed phone of (561) 409-2800. NPI 1972864064 was issued on 06/05/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCHIFFMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 708 prescription claims written by this provider, covering 232 Medicare beneficiaries and totaling roughly $364K in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7100 CAMINO REAL STE 121
BOCA RATON, FL 33433

Provider Details

NPI 1972864064
Specialty Allergy & Immunology Physician
Credentials MD
Gender Female
NPI Issued 06/05/2012

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMY SCHIFFMAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$4.1K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to AMY SCHIFFMAN, MD. To verify AMY SCHIFFMAN, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

AMY SCHIFFMAN, MD — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 708 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

708
Total Claims
$364K
Total Drug Cost
232
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,127
Total Day Supply
30,829
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$348K
Generic Drug Cost
$16K
Antibiotic Claims
36

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
1.26
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AMY SCHIFFMAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Montelukast Sodium
96
Prednisone
55
Ipratropium Bromide
48
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
48
Epinephrine
45
Symbicort
Budesonide/Formoterol Fumarate
43
Breo Ellipta
Fluticasone/Vilanterol
30
Albuterol Sulfate Hfa
Albuterol Sulfate
29
Triamcinolone Acetonide
28
Dupixent Pen
Dupilumab
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How AMY SCHIFFMAN, MD fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

AMY SCHIFFMAN, MD's 708 claims are below the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as SCHIFFMAN.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMY SCHIFFMAN, MD's specialty?
AMY SCHIFFMAN, MD specializes in Allergy & Immunology Physician and practices in BOCA RATON, Florida. Credentials: MD.
How much does AMY SCHIFFMAN, MD prescribe under Medicare Part D?
In 2023, AMY SCHIFFMAN, MD wrote 708 Medicare Part D claims totaling $364K in drug costs for 232 beneficiaries.
What is AMY SCHIFFMAN, MD's Medicare quality score?
AMY SCHIFFMAN, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is AMY SCHIFFMAN, MD located?
AMY SCHIFFMAN, MD is located at 7100 CAMINO REAL STE 121, BOCA RATON, FL, 33433. Phone: (561) 409-2800.
What is AMY SCHIFFMAN, MD's NPI number?
AMY SCHIFFMAN, MD's National Provider Identifier (NPI) is 1972864064, issued on 06/05/2012.
Does AMY SCHIFFMAN, MD prescribe more brand-name or generic drugs?
AMY SCHIFFMAN, MD's prescribing is 39% brand-name and 61% generic drugs by claim count, with $348K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does AMY SCHIFFMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, AMY SCHIFFMAN, MD's most frequently prescribed drugs include Montelukast Sodium, Prednisone, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMY SCHIFFMAN, MD accept Medicare?
AMY SCHIFFMAN, MD appears in CMS Medicare data with 708 Part D claims and 232 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMY SCHIFFMAN, MD's credentials?
AMY SCHIFFMAN, MD's NPI is 1972864064 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology